331 related articles for article (PubMed ID: 22340282)
41. Consensus recommendations on the use of daylight photodynamic therapy with methyl aminolevulinate cream for actinic keratoses in Australia.
See JA; Shumack S; Murrell DF; Rubel DM; Fernández-Peñas P; Salmon R; Hewitt D; Foley P; Spelman L
Australas J Dermatol; 2016 Aug; 57(3):167-74. PubMed ID: 26033230
[TBL] [Abstract][Full Text] [Related]
42. Pharmacoeconomic analysis of the treatment of multiple actinic keratoses.
Gold MH
J Drugs Dermatol; 2008 Jan; 7(1):23-5. PubMed ID: 18246694
[TBL] [Abstract][Full Text] [Related]
43. Comparison of "Lesion-by-Lesion" and Field Photodynamic Therapy in the Prevention of Actinic Keratoses: A Randomized, Split-Face, Single-Blind Pilot Study.
Seubring I; Groenewoud JMM; Gerritsen MP
Dermatology; 2016; 232(6):708-714. PubMed ID: 28095373
[TBL] [Abstract][Full Text] [Related]
44. A randomized, blinded, bilateral intraindividual, vehicle-controlled trial of the use of photodynamic therapy with 5-aminolevulinic acid and blue light for the treatment of actinic keratoses of the upper extremities.
Taub AF; Garretson CB
J Drugs Dermatol; 2011 Sep; 10(9):1049-56. PubMed ID: 22052276
[TBL] [Abstract][Full Text] [Related]
45. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials.
Piacquadio DJ; Chen DM; Farber HF; Fowler JF; Glazer SD; Goodman JJ; Hruza LL; Jeffes EW; Ling MR; Phillips TJ; Rallis TM; Scher RK; Taylor CR; Weinstein GD
Arch Dermatol; 2004 Jan; 140(1):41-6. PubMed ID: 14732659
[TBL] [Abstract][Full Text] [Related]
46. Topical corticosteroid reduces inflammation without compromising the efficacy of photodynamic therapy for actinic keratoses: a randomized clinical trial.
Wiegell SR; Petersen B; Wulf HC
Br J Dermatol; 2014 Dec; 171(6):1487-92. PubMed ID: 25060803
[TBL] [Abstract][Full Text] [Related]
47. Cost effectiveness of imiquimod 5% cream compared with methyl aminolevulinate-based photodynamic therapy in the treatment of non-hyperkeratotic, non-hypertrophic actinic (solar) keratoses: a decision tree model.
Wilson EC
Pharmacoeconomics; 2010; 28(11):1055-64. PubMed ID: 20936887
[TBL] [Abstract][Full Text] [Related]
48. Indole 3-acetic acid-photodynamic therapy in the treatment of multiple actinic keratoses: A proof of concept pilot study.
Grandi V; Baldi I; Cappugi P; Mori M; Pimpinelli N
Photodiagnosis Photodyn Ther; 2016 Dec; 16():17-22. PubMed ID: 27565032
[TBL] [Abstract][Full Text] [Related]
49. A randomized pilot comparative study of topical methyl aminolevulinate photodynamic therapy versus imiquimod 5% versus sequential application of both therapies in immunocompetent patients with actinic keratosis: clinical and histologic outcomes.
Serra-Guillén C; Nagore E; Hueso L; Traves V; Messeguer F; Sanmartín O; Llombart B; Requena C; Botella-Estrada R; Guillén C
J Am Acad Dermatol; 2012 Apr; 66(4):e131-7. PubMed ID: 22226430
[TBL] [Abstract][Full Text] [Related]
50. Single vs. fractionated photodynamic therapy for face and scalp actinic keratoses: a randomized, intraindividual comparison trial with 12-month follow-up.
Sotiriou E; Apalla Z; Chovarda E; Goussi C; Trigoni A; Ioannides D
J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):36-40. PubMed ID: 21366709
[TBL] [Abstract][Full Text] [Related]
51. Daylight photodynamic therapy for severe facial and scalp actinic keratosis: a prospective non-sponsored single-centre study employing the actinic keratosis area and severity index (AKASI).
Jordan M; Ghoreschi K; Eberle FC
Eur J Dermatol; 2019 Feb; 29(1):67-74. PubMed ID: 30827943
[TBL] [Abstract][Full Text] [Related]
52. Efficacy of 3 different light doses in the treatment of actinic keratosis with 5-aminolevulinic acid photodynamic therapy: a randomized, observer-blinded, intrapatient, comparison study.
Radakovic-Fijan S; Blecha-Thalhammer U; Kittler H; Hönigsmann H; Tanew A
J Am Acad Dermatol; 2005 Nov; 53(5):823-7. PubMed ID: 16243131
[TBL] [Abstract][Full Text] [Related]
53. Efficacy of imiquimod as an adjunct to cryotherapy for actinic keratoses.
Tan JK; Thomas DR; Poulin Y; Maddin F; Tang J
J Cutan Med Surg; 2007; 11(6):195-201. PubMed ID: 18042331
[TBL] [Abstract][Full Text] [Related]
54. Topical methyl aminolevulinate photodynamic therapy using red light-emitting diode light for multiple actinic keratoses: a randomized study.
Szeimies RM; Matheson RT; Davis SA; Bhatia AC; Frambach Y; Klövekorn W; Fesq H; Berking C; Reifenberger J; Thaçi D
Dermatol Surg; 2009 Apr; 35(4):586-92. PubMed ID: 19309347
[TBL] [Abstract][Full Text] [Related]
55. Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study.
Wiegell SR; Haedersdal M; Philipsen PA; Eriksen P; Enk CD; Wulf HC
Br J Dermatol; 2008 Apr; 158(4):740-6. PubMed ID: 18294318
[TBL] [Abstract][Full Text] [Related]
56. A randomized, double-blinded, placebo-controlled, multicenter, efficacy and safety study of 3.75% imiquimod cream following cryosurgery for the treatment of actinic keratoses.
Jorizzo JL; Markowitz O; Lebwohl MG; Bourcier M; Kulp J; Meng TC; Levy S
J Drugs Dermatol; 2010 Sep; 9(9):1101-8. PubMed ID: 20865842
[TBL] [Abstract][Full Text] [Related]
57. Randomized, double-blind, placebo-controlled prospective study of the efficacy of topical anaesthesia with a eutetic mixture of lignocaine 2.5% and prilocaine 2.5% for topical 5-aminolaevulinic acid-photodynamic therapy for extensive scalp actinic keratoses.
Langan SM; Collins P
Br J Dermatol; 2006 Jan; 154(1):146-9. PubMed ID: 16403108
[TBL] [Abstract][Full Text] [Related]
58. Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study.
Morton C; Campbell S; Gupta G; Keohane S; Lear J; Zaki I; Walton S; Kerrouche N; Thomas G; Soto P;
Br J Dermatol; 2006 Nov; 155(5):1029-36. PubMed ID: 17034536
[TBL] [Abstract][Full Text] [Related]
59. Topical photodynamic therapy of actinic keratoses with 5-aminolevulinic acid: randomized controlled trial with six months follow-up.
Buinauskaite E; Maciulaitis R; Buinauskiene J; Valiukeviciene S
J Dermatolog Treat; 2014 Dec; 25(6):519-22. PubMed ID: 24215475
[TBL] [Abstract][Full Text] [Related]
60. Pulse photodynamic therapy reduces inflammation without compromising efficacy in the treatment of multiple mild actinic keratoses of the face and scalp: a randomized clinical trial.
Wiegell SR; Petersen B; Wulf HC
Br J Dermatol; 2016 May; 174(5):979-84. PubMed ID: 26852899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
